⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
PM360 Announces 2026 Lifetime Achievement Award Honoree, CMO of the Year, and Brand Champions
prnewswire.com
LLY
JNJ
BMY
MRK
REGN
KURA
BMRN
TAK
VRTX
GSK
AZN
AMGN
ABBV
PRIVACY ALERT: Amgen Under Investigation for Data Breach of Records
prnewswire.com
AMGN
Form 8-K
sec.gov
AMGN
ПОЛОЖИТЕЛЬНАЯ ОЦЕНКА CHMP ПОДДЕРЖИВАЕТ БОЛЕЕ ШИРОКОЕ ПРИМЕНЕНИЕ ПРЕПАРАТА REPATHA® КОМПАНИИ AMGEN ДЛЯ СНИЖЕНИЯ РИСКА ПЕРВОГО ИНФАРКТА ИЛИ ИНСУЛЬТА
prnewswire.com
AMGN
Marquis Who's Who Honors Anshu Rajpurohit for Leadership in Corporate Accounting and Financial Operations
prnewswire.com
AMZN
AMGN
WLY
KLADNÉ STANOVISKO CHMP PODPORUJE ŠIRŠÍ POUŽITÍ PŘÍPRAVKU REPATHA® SPOLEČNOSTI AMGEN PŘED PRVNÍM INFARKTEM NEBO MOZKOVOU MRTVICÍ
prnewswire.com
AMGN
AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND
prnewswire.com
AMGN
POSITIVE STELLUNGNAHME DES CHMP UNTERSTÜTZT BREITERE ANWENDUNG VON AMGENS REPATHA® VOR ERSTEM HERZINFARKT ODER SCHLAGANFALL
prnewswire.com
AMGN
Peripheral Artery Disease Clinical Trial Pipeline Expands as 17+ Companies Race to Redefine Peripheral Artery Disease Treatment Landscape | DelveInsight
globenewswire.com
CLRS
MDT
PHG
BSX
BDX
BIOT
ABT
ANGI
RMAX
MRK
SNY
JNJ
BA
GSK
AZN
PFE
NVO
AMGN
VRTX
AVIS FAVORABLE DU CMUH CONCERNANT UNE UTILISATION PLUS LARGE DE REPATHA® D'AMGEN POUR REDUIRE LES RISQUES DE PREMIER INFARCTUS DU MYOCARDE OU D'AVC
prnewswire.com
AMGN